flanders.bio is an independent life sciences cluster organisation based in Flanders, Belgium

flanders.bio is a dynamic, member driven organisation with currently more than 350 members from Belgium and abroad. We help our members to create value by organising Networking and Training Activities, supporting Internationalisation, providing Services and building Expertise. flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.

News from flanders.bio and its members

Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer’s disease

Alzheimer’s disease (AD) is the most common form of dementia and increasing evidence has shown that neuroinflammation is an important and early hallmark of the pathogenesis. It has been suggested that tumor necrosis factor (TNF), a pro-inflammatory cytokine, might be detrimental in AD, though the results coming from clinical trials on anti-TNF inhibitors are inconclusive. Prof. Roosmarijn Vandenbroucke (VIB-UGent) reports in the authorative journal EMBO Molecular Medicine that TNF, via activation of its receptor TNFR1, is the main inflammatory upstream mediator of the AD-associated changes at the choroid plexus and that targeting TNF/TNFR1 signaling has therapeutic potential.

Patients | 22 February 18 Read more

MDxHealth financial results

MDxHealth SA ("MDxHealth, or the "Company"), (Euronext: MDXH.BR), today announced financial results for the financial year ended December 31, 2017 and provided an update on its strategic outlook.

Finance | 22 February 18 Read more

Ablynx announces 2017 full year results

Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced its financial results for the year ended 31st December 2017, which have been prepared in accordance with IFRS as issued by the IASB and adopted by the European Union, business highlights year-to-date and the outlook for the remainder of the year.

Biocartis Group NV: Biocartis kondigt 2017 financiële resultaten aan via webcast op 1 maart 2018

Biocartis Group NV (de 'Vennootschap' of 'Biocartis'), een innovatief bedrijf in de moleculaire diagnostiek, kondigt vandaag aan een live webcastconferentie op te zetten op donderdag 1 maart 2018 om 14:00 CET / 13:00 BST (VK) / 08:00 EDT (VS) om zijn 2017 resultaten en 2018 vooruitzichten aan te kondigen.

Finance | 22 February 18 Read more

flanders.bio events, trainings & international missions

Strategic Partners